Table 1.
Total | Group I <1 year |
Group II 1 < years < 2 |
Group III >4 years |
||
---|---|---|---|---|---|
SVM model training patients | |||||
Cases | 69 | 16 | 22 | 31 | |
ROI | HCC | 1369 | 219 | 558 | 592 |
non-HCC | 738 | 136 | 273 | 329 | |
Total | 2107 | 355 | 831 | 921 | |
Nuclei | HCC | 979,086 | 130,178 | 413,665 | 435,243 |
Normal | 328,463 | 57,437 | 120,702 | 150,324 | |
Total | 1,307,549 | 187,615 | 534,367 | 585,567 | |
Gender | M | 48 | 11 | 16 | 21 |
F | 21 | 5 | 6 | 10 | |
Age | Average | 65.4 | 65.8 | 67.0 | 64.0 |
MAX | 80 | 75 | 80 | 80 | |
MIN | 40 | 42 | 54 | 40 | |
Virus | HBV | 19 | 5 | 6 | 8 |
HCV | 36 | 8 | 13 | 15 | |
NBNC | 14 | 3 | 3 | 8 | |
Background | LC | 34 | 8 | 11 | 15 |
CH | 32 | 8 | 11 | 13 | |
Normal | 3 | 0 | 0 | 3 | |
Size (mm) | Average | 27.8 | 28.3 | 26.5 | 28.4 |
MAX | 48.0 | 48.0 | 43.0 | 47.0 | |
MIN | 9.0 | 20.0 | 9.0 | 10.0 | |
Nodule | Average | 1.3 | 1.7 | 1.1 | 1.2 |
MAX | 3 | 3 | 2 | 3 | |
MIN | 1 | 1 | 1 | 1 | |
SVM model test patients | |||||
Cases | 89 | 23 | 28 | 38 | |
ROI | HCC | 1346 | 434 | 324 | 588 |
non-HCC | 680 | 189 | 168 | 323 | |
Total | 2026 | 623 | 492 | 911 | |
Nuclei | HCC | 886,900 | 317,855 | 185,672 | 383,373 |
Normal | 251,376 | 66,243 | 59,148 | 125,985 | |
Total | 1,138,276 | 384,098 | 244,820 | 509,358 | |
Gender | M | 67 | 17 | 23 | 27 |
F | 22 | 6 | 5 | 11 | |
Age | Average | 67.8 | 68.2 | 71.3 | 65.1 |
MAX | 83 | 79 | 82 | 83 | |
MIN | 28 | 47 | 46 | 28 | |
Virus | HBV | 12 | 2 | 0 | 10 |
HCV | 53 | 16 | 17 | 20 | |
NBNC | 24 | 5 | 11 | 8 | |
Background | LC | 53 | 16 | 14 | 23 |
CH | 32 | 7 | 12 | 13 | |
NON | 4 | 0 | 2 | 2 | |
Size (mm) | Average | 26.3 | 38.5 | 27.7 | 24.2 |
MAX | 45.0 | 45.0 | 45.0 | 45.0 | |
MIN | 10.0 | 15.0 | 14.0 | 10.0 | |
Nodule | Average | 1.3 | 1.7 | 1.4 | 1.1 |
MAX | 3 | 3 | 3 | 2 | |
MIN | 1 | 1 | 1 | 1 |
HCC HCC area, non-HCC surrounding non-HCC area, ROI used ROI number, Nuclei calculated number of nuclei, NBNC neither HBV nor HCV infection.